Leuven tech company global player in AI analyses of brain scans
The AI models of Leuven-based icometrix examine the brain scans of patients suffering from neurological disorders, such as MS, Parkinson's, Alzheimer's, epilepsy and traumatic brain injuries. Now the company is gaining a foothold in the US.
Doctors analysing brain tissue are presented with cross-sectional recordings. This involves hundreds of vertical and horizontal slices, which must then be compared with previous recordings to detect and measure any changes. The correct analysis is extremely important for the most appropriate treatment or medication but sometimes the subtle differences are either invisible to the naked eye or incredibly hard to detect. Luckily, this is no problem for icometrix's AI technology. Its variety of algorithms, developed by the 200,000 scans used to feed the AI models, detect possible changes in structures, anomalies and lesions. Pixel by pixel. Has the brain volume shrunk, have lesions grown, and if so how much have they grown since the previous scan?
Some 200 hospitals and research centres worldwide, including some with great reputations, are already working with Leuven's world player in this field. They forward their scans via the cloud. And now that insurers are reimbursing icometrix's AI analyses in US hospitals at a cost of USD 235 per patient, the number of contract requests is increasing sharply. Excellent news for all concerned.